Viszeralchirurgie 2002; 37(3): 250-258
DOI: 10.1055/s-2002-32389
Originalarbeit
© Georg Thieme Verlag Stuttgart · New York

Die Bedeutung der Bluttransfusion in
der kolorektalen Tumorchirurgie

Significance of blood transfusion in colorectal cancerK.  Pfister1 , B.  Dietl2 , A.  Fürst1 , G.  Multhoff3 , K.-W.  Jauch1
  • 1Chirurgische Klinik und Poliklinik der Universität Regensburg
  • 2Strahlentherapie der Universität Regensburg
  • 3Hämatologie und internistische Onkologie der Universität Regensburg, AG Natürliche Killerzellen
Further Information

Publication History

Publication Date:
20 June 2002 (online)

Zusammenfassung

Mehr als die Hälfte aller Patienten mit kolorektalem Karzinom wird durch die tumorinduzierte Anämie und den perioperativen Blutverlust transfusionsbedürftig. Obwohl bisher der kausale Mechanismus nicht bekannt ist, gilt die fremdblutassoziierte Immunsuppression experimentell und klinisch als bewiesen. Eine Erhöhung der postoperativen Infektionsrate durch die Transfusion wird übereinstimmend bejaht, die Beeinträchtigung der Tumorprognose sowie eine erhöhte Rezidivrate jedoch kontrovers diskutiert. In dieser Übersichtsarbeit wurde die Literatur zum gesamten Themenkomplex zusammengetragen und analysiert. Die überwiegend retrospektiven Daten lassen derzeit keine definitive Beurteilung der klinischen Auswirkungen des negativen Transfusionseffektes zu. Dennoch sollte der Risikofaktor Bluttransfusion möglichst vermieden werden.

Abstract

More than half of all patients with colorectal cancer need blood transfusion because of tumor induced anemia or perioperative blood loss. Transfusion associated immunosuppression is a well known phenomenon although underlying mechanism is still not understood. Whereas in most studies concerning postoperative infection rate allogeneic blood transfusion had been an independent risk factor, controversial data have been published regarding the influence on colorectal cancer prognosis and tumor recurrence. The review analyzed the literature currently available. Clinical consequences of mainly retrospective surveys remain unclear. Therefore we suggest to avoid homologous blood transfusion wherever possible.

Literatur

  • 1 Hansen E, Taeger K, Hofstädter F. Die Retransfusion von Wundblut bei Tumorpatienten.  Dtsch Ärzteblatt. 1999;  41 B2097-2102
  • 2 Messmer K. Roundtable of Experts in Surgery Blood Management-Consensus Statement.  Infusionsther Transfusionmed. 1996;  23 143-146
  • 3 Kettelhack C, Hoenes C, Messinger D, Schlag P M. Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma.  Br J Surg. 1998;  85 63-67
  • 4 Geissmann D, Laffer U, Maibach R, Metzger U. SAKK . Transfusionsverhalten bei kurativ operierten Patienten mit kolorektalen Karzinomen.  Zentralbl Chir. 2000;  125 847-851
  • 5 Harder F, Laffer U, Berres M, Jäggi P, Metzger U. SAKK . Nach kurativer Resektion colorectaler Carcinome wirkt die portale Chemotherapie vor allem beim nicht-transfundierten Patienten.  Chirurg. 1990;  61 280-285
  • 6 Swiss Group for Clinical Cancer Research (SAKK) . Association between blood transfusion and survival in a randomised multicentre trial of perioperative adjuvant portal chemotherapy in patients with colorectal cancer.  Eur J Surg. 1997;  163 693-701
  • 7 Nicholls M D, Whyte G. Red cell, plasma and albumin transfusion decision triggers.  Anaesth Intens Care. 1993;  21 156-162
  • 8 Hallissey M T, Crowson M C, Kiff R S, Kingston R D, Fielding J W. Blood transfusion: an overused resource in colorectal cancer surgery.  Ann R Coll Surg Engl. 1992;  74 59-62
  • 9 American College of Physicians . Practice strategies for elective red blood cell transfusion.  Ann Intern Med. 1991;  116 403-406
  • 10 Standards for Blood Banks and Transfusion Services . Prepared by Committee on Standards.  American Association of Blood Banks. 1993;  15 35-38
  • 11 Sirchia G, Giovanetti A M. et al .Safe and good use of blood in surgery (SANGUIS). Use of blood products and artificial colloids in 43 European hospitals. Luxemburg: European Commission 1994
  • 12 Houston F, Foster J B, Chong A. et al . Transmissioin of BSE by blood transfusion in sheep.  Lancet. 2000;  356 999-1000
  • 13 Dodd R Y. Adverse consequences of blood transfusion: quantitative risk estimates. Nance ST ed Blood supply: risks, perceptions and prospects for the future. Bethesda: American Association of Blood Banks 1994: 1-24
  • 14 Taleghani M, Reith H B, Wiebecke D, Thiede A. Hämotherapie in der operativen Medizin.  Zentralbl Chir. 1999;  4 W27-41
  • 15 Opelz G, Sengar D PS, Mickey M R, Terasaki P I. Effect of blood transfusions on subsequent kidney transplants.  Transplant Proc. 1973;  5 253-259
  • 16 Opelz G, Terasaki P I. Improvement of kidney-graft survival with increased numbers of transfusions.  N Engl J Med. 1978;  299 799-803
  • 17 Heiss M M, Delanoff C. Immunmodulatorische Wirkung der Bluttransfusion und Einfluss auf Infektionsrate und Tumorrezidiv.  Infusionsther Transfusionmed. 1997;  24 20-31
  • 18 Houbiers J G, van de Velde C J, van de Watering L M, Hermans J, Schreuder S, Bijnen A B, Pahlplatz P, Schattenkerk M E, Wobbes T, de Vries J E, Klementschitsch P, van de Maas A H, Brand A. Transfusion of red cells in associated with increased incidence of bacterial infection after colorectal surgery: a prospective study.  Transfusion. 1997;  37 126-134
  • 19 Schricker K T, Hermanek P, Guggenmoos-Holzmann I, Neidhardt B, Resch T, Freudenberger K. Verschlechterung des Überlebens bei kolorektalem Karzinom. Überraschende Ergebnisse einer Multivarianzanalyse.  Beitr Infusionsther. 1990;  26 307-312
  • 20 Marsh J, Donnan P T, Hamer-Hodges D W. Association between transfusion with plasma and the recurrence of colorectal carcinoma.  Br J Surg. 1990;  77 623-626
  • 21 Blajchman M A, Bordin J O. Mechanisms of transfusion-associated immunosuppression.  Curr Opin Hematol. 1994;  1 457-461
  • 22 Waymack J P, Alexander J W. Blood transfusion as an immunomodulator: a review.  Comp Immunol Microbiol Infect Dis. 1986;  9 177-183
  • 23 Blumberg N, Heal J M. Transfusion and recipient immune function.  Arch Pathol Lab Med. 1989;  113 246-253
  • 24 Roth J A, Golub S H, Grimm E A, Eilber F R, Morton D L. Effects of operation on immune response in cancer patients: sequential evaluation of in vitro lymphocyte function.  Surgery. 1976;  79 46-51
  • 25 Hunt P S, Trotter S. Lymphocyte response after surgery and blood transfusion.  J Surg Res. 1976;  21 57-64
  • 26 Peller S, Sayfan J, Levy Y, Oland J, Yona R, Kaufman S, Orda R. Immunological profile changes following perioperative autologous vs. homologous blood transfusion in oncologic patients.  J Surg Oncol. 1994;  56 98-101
  • 27 Brivio F, Lissoni P, Redaelli R, Maggioni A, Rovelli F, Rescaldani R, Borin F, Erba L, Alderi G. Influence of blood transfusions on surgery-induced immune changes in colorectal carcinoma.  Miner Chir. 1993;  48 331-335
  • 28 Tartter P I, Steinberg B, Barron D, Martinelli G. Transfusion History, T Cell subsets and Natural killer cytotoxicity in Patients with colorectal cancer.  Vox Sang. 1989;  56 80-84
  • 29 Jensen L S, Andersen A J, Christiansen P M. et al . Post-operative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery.  Br J Surg. 1992;  79 513-516
  • 30 Ishijima N, Suzuki H. Blood transfusion and postoperative serum interleukin-6 levels in colorectal cancer patients.  Hepato-Gastroenterol. 1998;  45 1011-1013
  • 31 Ziv Y, Shohat B, Gelerenter I, Wolloch Y. The influence of perioperative transfusions on the immunological profile of patients with colorectal adenocarcinoma.  Panminerva Med. 1992;  34 4-12
  • 32 Mathiesen O, Lund L, Brodthagen U, Gandrup P, Grunnet N, Balslev I, Jersild C. The effect of previous blood transfusion on lymphocyte subsets and natural killer cell function in patients with colorectal cancer.  Vox Sang. 1994;  67 36-41
  • 33 Gantt C L. Red blood cells for cancer patients (letter).  Lancet. 1981;  ii 363
  • 34 van de Watering L MG. et al . Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery.  Circulation. 1998;  97 562-568
  • 35 Tartter P I, Quintero S, Barron D M. Perioperative Blood transfusion associated with infectious complications after colorectal cancer operations.  Am J Surg. 1986;  152 479-482
  • 36 Duffy G, Neal K R. Differences in post-operative infection rates between patients receiving autologous and allogeneic blood transfusion - a meta-analysis of published randomized and nonrandomized studies.  Transfus Med. 1996;  6 325-328
  • 37 Tartter P I. Blood transfusion and infectious complications following colorectal cancer surgery.  Br J Surg. 1988;  75 789-792
  • 38 Chiarugi M, Buccianti P, di Sarli M, Galatioto C, Goletti O, Cavina E. Association between perioperative blood transfusion and dehiscence of anastomosis after rectal resection for cancer.  Acta Chir Belg. 1996;  96 108-111
  • 39 Ford C D, VanMoorleghem G, Menlove R L. Blood transfusions and postoperative wound infection.  Surgery. 1993;  113 603-607
  • 40 Vignali A, Braga M, Gianotti L, Radaelli G, Gentilini O, Russo A, di Carlo V. A single unit of transfused allogeneic blood increases postoperative infections.  Vox Sang. 1996;  71 170-175
  • 41 Jaberth A V, Lee E T, Hersch E M, McBride C M. Effects of surgery, anesthesia and intraoperative blood loss on immunocompetence.  J Surg Res. 1973;  15 399-403
  • 42 Heald R J, Ryall R D. Recurrence and survival after total mesorectal excision after rectal cancer.  Lancet. 1986;  2 1479-1482
  • 43 Vamvakas E C, Carven J H. Transfusion of white-cell containing allogeneic blood components and postoperative wound infection: effect of confounding factors.  Transfusion Med. 1998;  8 29-36
  • 44 Vamvakas E C, Carven J H, Hibberd P L. Blood Transfusion and infection after colorectal cancer surgery.  Transfusion. 1996;  36 1000-1008
  • 45 Jensen L S, Hokland M, Nielsen H J. A randomized controlled study of the effect of bedside leucocyte depletion on the immunosuppressive effect of whole blood transfusion in patients undergoing elective colorectal surgery.  Br J Surg. 1996;  83 973-977
  • 46 Jensen L S, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery.  Lancet. 1996;  348 841-845
  • 47 Heiss M M, Mempel W, Jauch K W, Delanoff C, Mayer G, Mempel M, Eissner H J, Schildberg F W. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery.  Lancet. 1993;  342 1328-1333
  • 48 Heiss M M, Mempel W, Delanoff C, Mempel M, Jauch K W, Schildberg F W. Klinische Auswirkungen der mit einer Bluttransfusion assoziierten Immunmodulation auf das Ergebnis der Tumoroperation.  Infusionsther Transfusionsmed. 1993;  20 (Suppl 2) 25-29
  • 49 Jensen L S, Heiss M M, Mempel W, Jauch K W, Schildberg F W, Ross W B, Houbiers J GA, van de Watering L MG, Verwey P JM, van de Velde C JH, Brand A. Leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer.  Lancet. 1994;  344 1429-1431
  • 50 Houbiers J G, Brand A, van de Watering L M, Hermans J, Verwey P J, Bijnen A B, Pahlplatz P, Eeftinck S chattenkerk, Wobbes T, de Vries J E. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer.  Lancet. 1994;  344 573-578
  • 51 Busch O RC, Hop W CI, van Papendrecht M AV, Marquet R L, Jeekel J. Blood transfusions and prognosis in colorectal cancer.  N Engl J Med. 1993;  328 1372-1376
  • 52 Vignali A, Braga M, Dionigi P, Radaelli G, Gentilini O, Bellini A, Jemos V, di Carlo V. Impact of a programme of autologous blood donation on the incidence of infection in patients with colorectal cancer.  Eur J Surg. 1995;  161 487-492
  • 53 Parrot N R, Lennard T W, Taylor R M, Proud G, Shenton B K, Johnston I D. Effects of perioperative blood transfusion on recurrence of colorectal cancer.  Br J Surg. 1986;  73 970-973
  • 54 Burrows L, Tartter P, Aufses A. Increased recurrence rates in perioperatively transfused colorectal malignancy patients.  Cancer Detect Prev. 1987;  10 361-369
  • 55 Creasy T S, Veitch P S, Bell P R. A relationship between perioperative blood transfusion and recurrence of carcinoma of the sigmoid colon following potentially curative surgery.  Ann R Coll Surg Engl. 1987;  69 100-103
  • 56 Beynon J, Davies P W, Billings P J. et al . Perioperative blood transfusion increases the risk of recurrence in colorectal cancer.  Dis Colon Rectum. 1989;  29 975-979
  • 57 Mecklin J P, Jarvinen J H, Ovaska J T. Blood transfusion and prognosis in colorectal carcinoma.  Scand J Gastroenterol. 1989;  24 33-39
  • 58 Wobbes T, Joosen K H, Kuypers H H, Beerthuizen G I, Theeuwes A G. The effect of packed cells and whole blood transfusions on survival after curative resection for colorectal carcinoma.  Dis Colon Rectum. 1989;  32 743-748
  • 59 Blumberg N, Chuang-Stein C, Heal J M. The relation-ship of blood transfusion, tumor staging, and cancer recurrence.  Transfusion. 1990;  30 291-294
  • 60 Kijems E, Schydlowski P, Sondergaard J O. The influence of blood transfusions upon the recurrence rate of colorectal cancer.  Rev Med Chir Soc Med Nat Iasi. 1991;  95 265-268
  • 61 Tang R, Wang J Y, Chang-Chien C R, Chen J S, Lin S E, Hong A F. The asssociation between perioperative blood transfusion and survival of patients with colorectal cancer.  Cancer. 1993;  72 341-348
  • 62 Frankish P D, McNee R K, Alley P G, Woodfield D G. Relation between cancer of the colon and blood transfusion.  BMJ. 1985;  290 1827
  • 63 Francis D M, Judson R T. Blood transfusion and recurrence of cancer of the colon.  Br J Surg. 1987;  74 26-30
  • 64 van Lawick X, Pabst W P, Lagenhorst B L, Mulder P G, Marquet R L, Jeekel J. Effect of perioperative blood loss and perioperative blood transfusions on colorectal cancer survival.  Eur J Cancer Clin Oncol. 1988;  24 741-747
  • 65 Cheslyn-Curtiss S, Fielding L P, Hittinger R, Fry J S, Phillips R K. Large bowel cancer: the effect of perioperative blood transfusion on outcome.  Ann R Coll Surg Engl. 1990;  72 53-59
  • 66 Edna T H, Bjerkeset T. Perioperative blood transfusions reduce long-term survival following surgery for colorectal cancer.  Dis Colon Rectum. 1998;  41 451-459
  • 67 The Swiss Group for Clinical Cancer Research . Association between blood transfusion and survival in a randomised multicentre trial of perioperative adjuvant portal chemotherapy in patients with colorectal cancer.  Eur J Surg. 1997;  163 693-701
  • 68 Hermanek P. Beeinflussen perioperative Bluttransfusionen die Prognose von Patienten mit kolorektalem Karzinom?.  Strahlenther Onkologie. 1996;  172 283-284
  • 69 Blumberg N, Heal J M. Perioperative blood transfusion and colorectal cancer recurrence.  Transfusion. 1994;  34 450-452
  • 70 Leite J F, Granjo M E, Martins M I, Reis R C, Monteiro J C, Castro-Sousa F. Effect of perioperative blood transfusions on survival of patients after radical surgery for colorectal cancer.  Int J Colorectal Dis. 1993;  8 129-133
  • 71 Jahnson S, Andersson M. Adverse effects of perioperative blood transfusion in patients with colorectal cancer.  Eur J Surg. 1992;  158 419-425
  • 72 Faenza A, Cusolo A, Selleri S, Lucarell S, Farneti P A, Gozzetti G. Correlation between plasma or blood transfusion and survival after curative surgery for colorectal cancer.  Int Surg. 1992;  77 264-269
  • 73 Tartter P I. The association of perioperative blood transfusion with colorectal cancer recurrence.  Ann Surg. 1992;  216 633-638
  • 74 Zimmermann T, Dobroschke J, Borowek U, Padberg W. Der Einfluss der perioperativen Fremdblutgabe auf die Prognose des kolorektalen Karzinoms.  Zentralbl Chir. 1991;  116 1125-1138
  • 75 Weiden P L. Do perioperative blood transfusions increase the risk of cancer recurrence?.  Eur J Cancer. 1990;  26 987-989
  • 76 Liewald F, Wirsching R P, Zuelke C, Demmel N, Mempel W. Influence of blood transfusions on tumor recurrence and survival rate in colorectal carcinoma.  Eur J Cancer. 1990;  26 327-335
  • 77 Freiman J A, Chalmers T C, Smith H, Kuebler R R. The importance of beta, the type II error and sample size in the design and interpretation of randomized controlled trial.  N Engl J Med. 1978;  299 690-694
  • 78 Chung M, Steinmetz O K, Gordon P H. Perioperative blood transfusion and outcome after resection for colorectal carcinoma.  Br J Surg. 1993;  80 427-432
  • 79 Vamvakas E, Moore S B. Perioperative blood transfusion and colorectal cancer recurrence: a qualitative statistical overview and meta-analysis.  Transfusion. 1993;  33 754-765
  • 80 Vamvakas E C. Perioperative blood transfusion und cancer recurrence: meta-analysis for explanation.  Transfusion. 1995;  35 760-768
  • 81 Amato A C, Pescatori M. Effect of perioperative blood transfusions on recurrence of colorectal cancer: Meta-analysis stratified on risk factors.  Dis Colon Rectum. 1998;  41 570-585
  • 82 Vamvakas E C. Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized, controlled clinical trials.  Transfusion. 1996;  36 175-186
  • 83 Busch O RC, Hop W CJ, Marquet R L, Jeekel J. Prognostic impact of blood transfusions on disease-free survival in colorectal carcinoma.  Scand J Gastroenterol. 1993;  (Suppl) 21-23
  • 84 Busch O RC, Hop W CJ, Marquet R L, Jeekel J. The effect of blood transfusions on survival after surgery for colorectal cancer.  Eur J Cancer. 1995;  31A 1226-1228
  • 85 Molland G, Dent O F, Chapuis P H, Bokey E L, Nicholls M, Newland R C. Transfusion does not influence patient survival after resection of colorectal cancer.  Aust Nz J Surg. 1995;  65 592-595
  • 86 Donohue J H, Williams S, Cha S, Windschitl H E, Witzig T E, Nelson H, Fitzgibbons R J, Wieand H S, Moertel C G. Peroperative blood transfusions do not affect disease recurrence of patients undergoing curative resection of colorectal carcinoma: a Mayo/North Central Cancer Treatment Group study.  J Clin Oncol. 1995;  13 1671-1678
  • 87 Busch O R, Hop W C, Marquet R L, Jeekel J. Blood transfusions and local tumor recurrence in colorectal cancer. Evidence of a noncausal relationship.  Ann Surg. 1994;  220 791-797
  • 88 Steup W H, Hojo K, Moriya Y, Sugihara K, Mizuno S, Hermans J, van de Velde C J. An analysis on the effect of blood transfusion on recurrence and survival in patients undergoing extended lymphadenectomy for colorectal cancer.  Hepato-Gastroenterol. 1994;  41 253-259
  • 89 Garau I, Benito E, Bosch F X, Bargay J, Obrador A, Santamaria J, Antich J L, Besalduch J, Rifa J, Teuchmann S. Blood transfusion has no effect on colorectal cancer survival. A population-based study.  Eur J Cancer. 1994;  30A 759-764
  • 90 Sibbering D M, Locker A P, Hardcactle J D, Armitage N C. Blood transfusion and survival in colorectal cancer.  Dis Colon Rectum. 1994;  37 358-364
  • 91 Ford C D, Gillette J W, Handrahan D L, Koehler C S. Transfusion and second malignancy.  Transfusion. 1994;  34 63-65
  • 92 Sene A, Jeacock J, Robinson C, Walsh S, Kingston R D. Blood transfusion does not have an adverse effect on survival after operation for colorectal cancer.  Ann R Coll Surg Engl. 1993;  75 261-266
  • 93 Modin S, Karlsson G, Wahlby L. Blood transfusion and recurrence of colorectal cancer.  Eur J Surg. 1992;  158 371-375
  • 94 Bentzen S M, Balslev I, Pedersen M, Teglbjaerg P S, Hanberg-Sorensen F, Bone J, Jacobsen N O, Sell A, Overgaard J, Bertelsen K. et al . Blood transfusion and prognosis in Dukes' B and C colorectal cancer.  Eur J Cancer. 1990;  26 457-463
  • 95 Jakobsen E B, Eickhoff J H, Andersen J, Lundvall L, Stenderup J K. Perioperative blood transfusion and recurrence and death after resection for cancer of the colon and rectum.  Scand J Gastroenterol. 1990;  25 435-442
  • 96 McAlister F A, Clark H D, Wells P S, Laupacis A. Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: A meta-analysis of unconfounded studies.  Br J Surg. 1998;  85 171-178
  • 97 Busch O RC, Marquet R L, Hop W CI, Jeekel J. Colorectal cancer recurrence and perioperative blood transfusions: A critical reappraisal.  Sem Surg Oncol. 1994;  10 195-199
  • 98 Heiss M M, Mempel W, Delanoff C, Jauch K W, Gabka C, Mempel M, Dieterich H J, Eissner H J, Schildberg F W. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery.  J Clin Oncol. 1994;  12 1859-1867
  • 99 Francis D MA. Relationship between blood transfusion and tumour behaviour.  Br J Surg. 1991;  78 1420-1428
  • 100 Nielsen H J. Detrimental effects of perioperative blood transfusion.  Br J Surg. 1995;  82 582-587
  • 101 Singh S K, Marquet R L, de Bruin R WF, Westbroek D L, Jeekel J. Promotion of tumour growth by blood transfusions.  Transplant Proc. 1987;  19 1473-1474
  • 102 Tartter P I, Francis D M. Blood transfusion and tumor growth.  Transplant Proc. 1988;  20 1108-1111
  • 103 Hebert P C. et al . A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care.  NEJM. 1999;  340 409-417
  • 104 Hogue C W, Goodnough L T, Monk T G. Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy.  Transfusion. 1998;  38 924-993
  • 105 Marquet R L, de Bruin R W, Dallinga R, Singh S K, Jeekel J. Modulation of tumor growth by allogenic blood transfusion.  J Cancer Res Clin Oncol. 1986;  11 50-53
  • 106 Singh S K, Marquet R L, de Bruin R W, Hop W C, Westerbroek D L, Jeekel J. Consequences of blood loss on growth of artificial metastases.  Br J Surg. 1988;  75 377-379
  • 107 Francis D M, Shenton B K, Proud G, Taylor R M. Tumor growth and blood transfusion.  J Exp Clin Cancer Res. 1982;  1 121-126
  • 108 Eggermont A M, Stellar E P, Sugarbaker P H. Laparotomy enhances intraperitoneal tumor growth and abrogates the antitumor effects of interleukin-2 and lymphokine-activated killer cells.  Surgery. 1987;  102 71-78
  • 109 Bordin J O, Bardossy L, Blajchman M A. Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leucodepletion.  Blood. 1994;  84 344-348
  • 110 de Canniere L, Rosiere A, Michel L A. Synchronous abdominoperineal resection without transfusion.  Br J Surg. 1993;  80 1194-1195
  • 111 Taleghani M, Grossmann R, Reith H B, Wiebecke D, Thiede A. Fremdblutsparende Maßnahmen in der operativen Medizin.  Zentralbl Chir. 2000;  125 111-122
  • 112 Leben J, Schregel W. Ist perioperative Wärmung wirtschaftlich vertretbar oder ist Nicht-Wärmung heute noch wirtschaftlich vertretbar?.  J Anästh Intensiv. 2001;  3 171-173
  • 113 Siebeck M, Schorr M, Heckl U. et al .Effekt von Aprotinin auf Blutverlust und Transfusion beim Rektumresektionen. Postersitzung Viszeralchirurgie und Forschung. Wiss. Referate 77. Tagung Ver. Bayer. Chir 2000
  • 114 Lentschener C, Benhamou D, Mercier F J. et al . Aprotinin reduces blood loss in patients undergoing elective liver resection.  Anest Analg. 1997;  84 (4) 875-881
  • 115 Porte R J, Molenaar I Q, Begliomini B. et al . Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group.  Lancet. 2000;  355 (9212) 1303-1309
  • 116 Hedner U. Recombinant activated factor VIIa as a universal haemostatic agent.  Blood Coag Fibrinol. 1998;  9 (Suppl 1) 147-152
  • 117 Ehrenforth S. Therapeutic potential of recombinant activated factor VII in intensive care medicine.  J Anästh Intensiv. 2001;  3 110-112
  • 118 Larocque B J, Gilbert K, Brien W F. A point score system for predicting the likelihood of blood transfusion after hip or knee arthroplasty.  Transfusion. 1997;  37 463-467
  • 119 Hansen E, Altmeppen J, Taeger K. Autologous haemotherapy in malignant diseases. Clinical anaesthesiology: Blood, blood products and blood saving techniques. Kretschmer V, Blauhut B (eds). 1997 6: 335-350
  • 120 Mac Douglas N. The patient's blood is the safest blood.  N Engl J Med. 1987;  316 542-544
  • 121 Mempel W, Lehr L. Präoperative Eigenblutspende und -bereitstellung.  Chiurg. 1994;  65 1075-1079
  • 122 Bormann von B, Aulich S. Autologe Transfusionsverfahren: Nutzen und Risiko.  Dtsch Ärzteblatt. 1993;  90 2912-2918
  • 123 Jaffray B. Predeposit autologous blood transfusion in patients with colorectal cancer: a feasibility study.  Br J Surg. 1992;  79 977
  • 124 Hoynck von X, Papendrecht M A, Hop W, Langenhorst B L, Kothe F C, Marquet R L, Jeekel J. Feasibility of a predeposit autologous blood donation program in colorectal cancer patients: Results from a randomized clinical study.  Vox Sang. 1992;  62 102-107
  • 125 Harrison S, Steele R JC, Johnson A K. et al . Predeposit autologous blood transfusion in patients with colorectal cancer: a feasibility study.  Br J Surg. 1992;  79 355-357
  • 126 Linden J V, Wagner K, Voytovich A E, Sheehan J. Transfusion errors in New York State: an analysis of 10 years' experience.  Transfusion. 2000;  40 1207-1213
  • 127 Popovsky M A, Whitaker B, Arnold N L. Severe outcomes of allogeneic and autologous blood donation frequency and characterization.  Transfusion. 1995;  35 734-737
  • 128 Blutmanagement in der Chirurgie. Symposium St. Barbara Hospital Gladbeck
  • 129 Kiesewetter H, Jung F, Koscielny J, Pindur G, Wenzel E. Qualitätssicherung bei der Eigenblutentnahme von kritisch Kranken.  Beitr Infusionsther. 1993;  31 202-208
  • 130 Heiss M M, Fraunberger P, Delanoff C, Stets R, Allgayer H, Stroehlein M A, Tarabichi A, Faist E, Jauch K W, Schildberg F W. Modulation of immune response by blood transfusion: evidence for a differential effect of allogeneic and autologous blood in colorectal cancer surgery.  Shock. 1997;  8 402-408
  • 131 Heiss M M, Fasol-Merten K, Allgayer H, Stroehlein M A, Tarabichi A, Wallner S, Eissner H I, Jauch K W, Schildberg F W. Influence of autologous versus allogeneic blood transfusion on natural killer and lymphokine-activated killer cell activities in cancer surgery.  Vox Sang. 1997;  73 237-245
  • 132 AuBuchon J P, Birkmeyer J D. Controversies in transfusion medicine.  Is autologous blood transfusion worth the cost? Transfusion. 1994;  34 79-83
  • 133 Goldfinger D, Haimowitz M. Controversies in transfusion medicine. Is autologous blood transfusion worth the cost?.  Transfusion. 1994;  34 75-78
  • 134 Etchason J, Petz L, Keeler E. et al . The cost effectiveness of preoperative autologous blood donations.  N Engl J Med. 1995;  332 719-724
  • 135 Birkmeyer J D, AuBuchon J P, Littenberg B. et al . Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting.  Ann Thorac Surg. 1994;  57 161-168
  • 136 Birkmeyer J D, Goodnough L T, AuBuchon J P, Littenberg B. et al . The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement.  Transfusion. 1993;  33 544-551
  • 137 Lane T A. The effect of storage on the metastatic potential of tumor cells collected in autologous blood.  Transfusion. 1989;  29 418-420
  • 138 Mynster T, Nielsen H J. The impact of storage time of transfused blood on postoperative infectious complications in rectal cancer surgery.  Scand J Gastroenterol. 2000;  35 212-217
  • 139 Marquet R L, Busch O R, Jeekel J, Heiss M M, Amato A C. Are allogeneic blood transfusions acceptable in elective surgery in colorectal carcinoma?.  Eur J Cancer. 1999;  35 352-360
  • 140 Edna T H, Bjerkeset T. Association between transfusion of stored blood and infective bacterial complications after resection for colorectal cancer.  Eur J Surg. 1998;  164 449-456
  • 141 Hoh H, Umpleby H, Cooper A, Taylor I. Recurrence of colorectal cancer and perioperative blood transfusion. Is blood storage time important?.  Dis Colon Rectum. 1990;  33 127-130
  • 142 Sibrowski W, Cassens U. Einfluss von Lagerung und Konservierung auf die Qualität von Blutzellen.  Anästhesiol Intensivmed Notfallmed Schmerzther. 1998;  33 673-675
  • 143 Blajchman M A. Immunomodulatory effects of allogeneic blood transfusions: clinical manifestations and mechanisms.  Vox Sang. 1998;  74 (Suppl 2) 315-319
  • 144 Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten Hämotherapie. Neu bearbeitete Fassung. Deutscher Ärzte-Verlag Köln 2000
  • 145 Prionen-Forschung und -Diagnostik. Vom BSE-Schnelltest bis zum Nachweis von Prionen im Blut. Dtsch Ärzteblatt 2000 49: B2786-2788
  • 146 Turner M L, McClelland D BL. The role of r-HuEPO in surgical transfusion practice.  Erythropoiesis. 1995;  6 107-113
  • 147 Henry D H. Recombinant human erythropoietin in the treatment of the anemia associated with solid tumors. Bauer C, Koch KM et al Epo-molecular physiology and clinical applications. NY, Marcel Dekker 1994: 293ff
  • 148 Heiss M M, Tarabichi A, Allgayer H, Jauch K W, Mempel W, Schildberg F W, Messmer K. Perisurgical erythropoietin application in anemic patients with colorectal cancer: a double-blind randomized study.  Surgery. 1996;  5 523-527
  • 149 Eckardt K U. Erythropoietin: Karriere eines Hormons.  Dtsch Ärzteblatt. 1998;  6 B245-250
  • 150 Rationale für den Einsatz von Erythropoetin in der Tumortherapie. Beilage in „Der Onkologe” 2000 6 8
  • 151 Erythropoietin in der Tumortherapie. Beilage in „Der Onkologe” 1999 5 2
  • 152 Erythropoietin - neue Aspekte für die Tumortherapie. Beilage in „Der Onkologe” 1999 5 6
  • 153 Die Bedeutung von Epoetin alfa bei der Behandlung operativer Blutverluste. Expertenmeeting in Wien 7. .4..1995
  • 154 Goodnough L T, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis.  Blood. 2000;  96 823-833
  • 155 Scigalla P, Franke W, Messinger D. Rationale für die Eigenblutspende in der elektiven Chirurgie mit oder ohne Einsatz von rekombinanten, humanem Erythropoietin in Innovative Aspekte der klinischen Medizin. Springer 1994 3
  • 156 Die Rolle von rhErythropoietin im Rahmen fremdblutsparender Methoden. Beilage in „Der Chirurg” 1994 65 4
  • 157 Rau B, Schlag P M, Willeke F, Herfarth C, Stephan P, Franke W. Increased autologous blood donation in rectal cancer by recombinant human erythropoietin.  Eur J Cancer. 1998;  34 992-998
  • 158 Jeekel J. Autologous blood donation and epoetin alfa in cancer surgery.  Semin Hematol. 1996;  33 (2 Suppl 2) 43-46, discussion 47
  • 159 Ludwig H, Fritz E. Pathogenese und Therapie der therapie- und tumorbedingten Anämie. Kompendium Internistische Onkologie, Springer 1996: 1118-1127
  • 160 Ludwig H, Fritz E, Leitgeb C, Krainer M, Kührer I, Sagaster P, Umek H. Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors.  Ann Oncol. 1993;  4 61-167
  • 161 Cazzola M, Mercuriali F, Brugnara C. Use of recombinant erythropoietin outside the setting of uremia.  Blood. 1997;  89 4248-4267
  • 162 Levine E A, Laborde C, Hambrick E. et al . Influence of Erythropoietin on Transfusion Requirements in Patients Receiving Preoperative Chemoradiotherapy for Rectal Cancer.  Dis Colon Rectum. 1999;  42 1065-1071
  • 163 Glaser G, Millesi W, Wanschitz F, Schüll B, Lang S, Leitha T, Kornek G V. R-HuErythropoietin treatment increases efficacy of neoadjuvant radiochemotherapy and improves cancer free survival of patients with oral squamous cell carcinoma.  Proc Am Soc Clin Oncol. 1999;  18 399a
  • 164 Hoeckel M, Schlenger K, Aral B, Mitze M, Schäffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix.  Cancer Res. 1996;  56 4509-4515
  • 165 Henke M, Guttenberger R. Erythropoietin in Radiation Oncology - A Review.  Oncology. 2000;  58 175-182
  • 166 Die Bedeutung erhöhter Hämoglobinspiegel für Tumoroxygenierung, Radiotherapie und Prognose. Beilage in „Der Onkologe” 1998 4 3
  • 167 Glimelius B, Linné T, Hoffmann K. et al . Epoetin Beta in the Treatment of Anemia in Patients With Advanced Gastrointestinal Cancer.  J Clin Oncol. 1998;  16 434-440
  • 168 Nowrousian M R. Behandlung der tumor- oder chemotherapiebedingten Anämie mit Erythropoietin. Remission 2-99
  • 169 Westphal G. et al .Experimental data concerning safety profile of rhEpo in the treatment of cancer patients. Smith JF, Boogaerts MA and Ehmer BRM (eds) rh Erythropoietin in Cancer Supportive Treatment. 1996: 149-158
  • 170 Sowade B. et al . The safety of treatment with recombinant humanerythropoietin in clinical use: A review of controlled studies.  Int J Mol Med. 1998;  1 303-314
  • 171 Weisbach V, Eckstein R. Eisenhaushalt und präoperative Eigenblutspende.  Infusionsther Transfusionsmed. 1996;  23 161-170
  • 172 Habler O, Kleen M, Meßmer K. Künstliche Sauerstoffträger. Alternativen zur Fremdbluttransfusion?.  Zentralbl Chir. 1999;  124 260-270

Dr. K. Pfister

Chirurgische Klinik und Poliklinik der Universität Regensburg

Franz-Josef-Strauß-Allee 11

93053 Regensburg

Phone: 0941-9446801

Fax: 0941-9446802

Email: Karin.pfister@Klinik.uni-regensburg.de